Navigation Links
FDA funds pediatric trial testing genetically reprogrammed HSV to treat cancer
Date:10/12/2010

to attack cancer cells in other ways such as activating certain types of chemotherapies in a one-two punch or destroying blood vessels that feed tumors. Research in mouse models of human cancer by Cripe's laboratory has shown oncolytic HSV agents to be effective at shrinking a variety of modeled tumor types, suggesting a possible approach for treating human disease.

"Our goal in the current HSV1716 trial is to light a fire to the cancer so that the virus replicates and spreads to the cancer cells," Dr. Cripe explained. "We have to take this one step at a time and the initial phase of the trial focuses on making sure the virus doesn't cause adverse side effects. It has been tested in Europe in adults with brain cancer, squamous cell carcinoma and melanoma and shown in those trials to be safe."

HSV1716 has also been tested extensively for safety in animal models at Cincinnati Children's Hospital by Dr. Cripe and in Europe prior to it being tested in people.

The Phase I trial will include up to 18 patients and is expected to last three years. The optimum safe dosing for this virus is unknown, so the study will sequentially increase dosing levels in small groups of patients and observe for side effects as the trial proceeds. This earliest phase tests the lowest dose on older children and young adults with solid tumor cancers who have limited or no standard therapy options available.

The researchers plan to add younger patients with earlier stages of cancer as the trial proceeds. They will not be able to determine if the safety trial is successful until all patients have received treatment and the results analyzed. As with all clinical trials of new anticancer therapies in patients, many factors can influence the risk for severe side effects and anticancer activity. Even though HSV1716 may cause tumor shrinkage in mouse models of pediatric cancer, it may not have antitumor effect in patients.


'/>"/>

Contact: Nick Miller
nicholas.miller@cchmc.org
513-803-6035
Cincinnati Children's Hospital Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. NIH funds Center of Excellence for Molecular Hematology at Cincinnati Childrens
2. $1.5M grant funds research aimed at reducing strokes in children with sickle cell disease
3. NIH funds center at Arizona State to battle infectious diseases
4. French national research agency funds PREDIMOL project
5. NHGRI funds development of third generation DNA sequencing technologies
6. $22.5 million grant funds international study of membrane proteins
7. NSF funds innovative approach to biomimetic nanofiber bone regeneration
8. Gulf oil spill: NSF funds research on impacts to Florida Everglades
9. NSF funds Virginia Tech program to train researchers at intersection of engineering, biology
10. NIH funds multicenter glue grant to study enzyme function
11. California funds UCI basic research on stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... An international team of scientists using a new X-ray ... a living frog embryo in greater detail than ever ... biological research and the search for new treatments for ... Institut fr Technologie in Germany, in collaboration with the ... Argonne National Laboratory, released the most precise depiction ever ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) ... The Endocrine Society (ENDO) 95th Annual Meeting in ... awards are meant to promote the entry of ... the mainstream of the basic science community and ... the ENDO 2013 Annual Meeting. , Awards are ...
(Date:5/16/2013)... African-American adults living closer to a fast food restaurant ... who lived further away from fast food, according to ... Center, and this association was particularly strong among those ... published online in the American Journal of Public ... to a fast food restaurant, and among lower-income African-Americans, ...
Breaking Biology News(10 mins):New X-ray method shows how frog embryos could help thwart disease 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3
... NEW YORK (FEBRUARY 13, 2008) The Wildlife Conservation ... a 5,000 mile-long genetic corridor from Bhutan to Burma ... landscapes. The corridor, first announced at the United Nations ... the largest block of tiger habitat left on earth. ...
... In an innovative program to help junior researchers, particularly ... American Society for Cell Biology (ASCB) today announced that ... for child care during the Societys 2008 Annual Meeting, ... Goldberg said that the $16,000 New Scholars grant from ...
... Washington Laws protecting the critically endangered Sumatran Tiger ... sold in Indonesia, according to a TRAFFIC report launched ... skin pieces, whiskers and bones, were on sale in ... 2006 in 28 cities and towns across Sumatra. Outlets ...
Cached Biology News:'Genetic corridors' are next step to saving tigers 2'Genetic corridors' are next step to saving tigers 3Cell biologists announce child-care grants for scientist-parents at annual meeting 2Body part by body part, Sumatran tigers are being sold into extinction 2
(Date:5/16/2013)... (PRWEB) May 16, 2013 ... Barbara A. Myers, CAE, to the newly created ... her new role, Myers will be responsible for ... and production strategies, advancing the Society’s Member-led and ... and continuing to refine organizational, membership and product ...
(Date:5/16/2013)... Kitware , a leading provider of scientific ... SBIR funding from the U.S. Department of Energy ... performance computing (HPC) simulation and computation framework. The ... only the toolkits and applications needed to perform ... , Manufacturers increasingly rely on simulation tools ...
(Date:5/16/2013)... On average, developing a new drug ... dollars. Despite this investment, less than 10% of drugs ... your clinical trial design optimally structured to balance time, ... Dr. Frederic Sax, Global Head of the Center for ... data, information and technology in upfront clinical trial planning ...
(Date:5/16/2013)... Dr. Stephen Y. Chou, Founder of Nanonex Corporation, will ... at IEEE Nano 2013 in Beijing, China, on August ... is becoming one of the most critical nanofabrication technologies ... resolution, large area, and low cost unmatchable by other ... in a broad range of industries, from ICs, nano/micro ...
Breaking Biology Technology:ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013 2
... Mass., May 14 Cynosure, Inc.,(Nasdaq: CYNO ... broad array of,light-based aesthetic treatment systems, today announced ... of global marketing. Lee will develop and,implement worldwide ... including the Smartlipo MPX, the company,s newest system,for ...
... MONTVALE, N.J., May 14 Memory Pharmaceuticals,Corp. (Nasdaq: ... for the first,quarter ended March 31, 2008., ... significant progress with,our collaborations and refocusing our operations ... President and Chief Executive Officer.,"Roche,s recent decision to ...
... StemCor Systems, Inc., a,medical device company developing ... it has been awarded a,National Institutes of Health ... "Adult Stem Cell Minimally Invasive Bone Marrow,Harvester." The ... received 510(k) clearance from the U.S. Food and ...
Cached Biology Technology:Cynosure Appoints H. Travis Lee as Vice President of Global Marketing 2Cynosure Appoints H. Travis Lee as Vice President of Global Marketing 3Memory Pharmaceuticals Reports First Quarter 2008 Financial Results 2Memory Pharmaceuticals Reports First Quarter 2008 Financial Results 3Memory Pharmaceuticals Reports First Quarter 2008 Financial Results 4Memory Pharmaceuticals Reports First Quarter 2008 Financial Results 5Memory Pharmaceuticals Reports First Quarter 2008 Financial Results 6Memory Pharmaceuticals Reports First Quarter 2008 Financial Results 7StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform 2StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform 3
... Sequencing Quality 96 Well ... BAC template preparation from 1.5ml ... suitable for automated fluorescent sequencing ... DNA; Utilizes ProPrep strategy which ...
Vesicular Glutamate Transporter 2 [VGLUT2]...
Mouse monoclonal [0.N.305] to G protein alpha - BSA and Azide free ( Abpromise for all tested applications). Antigen: Partially purified G protein alpha from rat brain. Entrez GeneID: 2778 ...
XIAP Antibody...
Biology Products: